Skip to main content

Table 3 Salvage RT patient group characteristics

From: Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT

Characteristics Salvage RT group
Patients (n) 17
Age (median) 69 (58–84)
Radical prostatectomy 17
TNM stage  
pT1-T2 11
pT3a-b 5
pT4 1
pN1 1
pNx 9
Mx 17
Gleason score  
6–7 8
8–9 8
Positive surgical margins after radical prostatectomy 5
Pre-PSMA-PET/CT PSA (ng/ml) (median) 2.8 (0.1–21.8)
Postoperative PSA (ng/ml) (median) 0.7 (0–7)
PSA (ng/ml) at PSMA-PET/CT in PET positive pts 1.6 (0.4–13.8)
PSA (ng/ml) at PSMA-PET/CT in PET negative pts 0.6 (0.1–1)
PSMA-PET/CT revealed metastases in  
FR only 6
Lymph nodes 7
Bones 1
FR and lymph nodes 1
  1. Pts, patients; PSA, prostate-specific antigen; PSMA-PET/CT, prostate-specific membrane antigen positron emission tomography/computed tomography; ADT, androgen deprivation therapy; LN, lymph nodes; FR, fossa recurrence; RT, radiation therapy